RecallRadar

FDA Drug recall D-498-2013

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Da…

On 2013-06-05 the FDA classified a Class III recall of Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Da… by Aurobindo Pharma Usa, citing labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-498-2013
ClassificationClass III
Statusterminated
Initiated2013-04-09
Published2013-06-05
Last updated2026-09-13 11:51 UTC
CompanyAurobindo Pharma Usa
DistributionUS

Product

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Reason

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

Identifiers

ndc65862-037-30
ndc65862-037-01
ndc65862-037-00
ndc65862-037-05
ndc65862-037-99
ndc65862-038-30
ndc65862-038-01
ndc65862-038-00
ndc65862-038-05
ndc65862-038-99
ndc65862-039-30
ndc65862-039-01
ndc65862-039-00
ndc65862-039-05
ndc65862-039-99
ndc65862-040-30
ndc65862-040-01
ndc65862-040-00
ndc65862-040-05
ndc65862-040-99
ndc65862-041-30
ndc65862-041-01
ndc65862-041-00
ndc65862-041-05
ndc65862-041-99
ndc65862-042-30
ndc65862-042-01
ndc65862-042-00
ndc65862-042-05
ndc65862-042-99
code_infoLot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-498-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.